Impaired GCGR signaling could disrupt these regulatory axes, thus contributing to hyperglycemia and insulin resistance—2 conditions associated with cognitive decline and dementia—as well as metabolic dysregulation. This evidence concerns the gene GCGR and Insulin resistance.